If you could vote on Brexit now which option would you choose?
   

India approves Roche/Regeneron antibody cocktail to treat COVID-19


India has given emergency use authorization for a COVID-19 antibody drug cocktail developed by Roche (ROG.S) and Regeneron (REGN.O), expanding its arsenal of drugs to battle a massive second wave of infections. The decision was taken based on data filed with the U.S. regulators and the scientific opinion of a European regulatory panel, Roche's India distribution partner for the drug, Cipla (CIPL.NS), said on Wednesday. The therapy is a cocktail of two antibodies Casirivimab and Imdevimab, which are synthetically manufactured copies of antibodies that the body produces after an infection.

Reuters India - May 5, 2021

View the full story here: https://www.reuters.com/world/india/india-approves-rocheregeneron-drug-covid-19-2021-05-05/